Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 01/16/2026 | PUT | $80.00 | 872 | +365 | +71.99% |
| 01/17/2025 | CALL | $42.00 | 374 | +171 | +84.24% |
| 01/17/2025 | PUT | $45.00 | 2,365 | +89 | +3.91% |
| 01/17/2025 | PUT | $40.00 | 2,776 | +62 | +2.28% |
| 01/24/2025 | PUT | $38.00 | 72 | +50 | +227.27% |
| 02/14/2025 | PUT | $41.00 | 77 | +50 | +185.19% |
| 01/10/2025 | PUT | $48.00 | 0 | -22 | -100.00% |
| 01/24/2025 | CALL | $40.00 | 104 | -48 | -31.58% |
| 01/10/2025 | PUT | $37.00 | 521 | -50 | -8.76% |
| 01/10/2025 | PUT | $47.00 | 54 | -59 | -52.21% |
| 01/17/2025 | PUT | $55.00 | 348 | -223 | -39.05% |
| 01/17/2025 | PUT | $110.00 | 0 | -915 | -100.00% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| ARK ETF Tr-ARK Innovation ETF | 7.14% | 5.61M | 322.69M |
| New Perspective Fund Inc | 4.51% | 3.55M | 204.09M |
| ARK ETF Tr-ARK Genomic Revolution ETF | 1.97% | 1.55M | 89.07M |
| SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 1.78% | 1.4M | 80.32M |
| Vanguard Extended Market Index Fund | 1.34% | 1.05M | 60.37M |
| Price (T.Rowe) Mid Cap Growth Fund | 1.21% | 950k | 54.61M |
| Growth Fund Of America Inc | 1.02% | 800.87k | 46.03M |
| Smallcap World Fund | 0.95% | 746.3k | 42.9M |
| iShares NASDAQ Biotechnology ETF | 0.76% | 600.21k | 34.5M |
| Fidelity Growth Company Fund | 0.75% | 589.59k | 33.89M |
Gene Therapy Market Analysis,Growth, Insights and Future Outlook | Exactitude Consultancy
12/26 08:18 am
GlobeNewswire Inc.
Read moreThis Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy?
12/22 01:25 pm
The Motley Fool
Read moreShould You Buy Vertex Pharmaceuticals on the Dip Before Potentially Enormous News in January 2025?
12/22 05:30 am
The Motley Fool
Read more1 Reason to Sell DexCom Stock, and 1 Reason to Buy
12/21 07:45 am
The Motley Fool
Read more2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio?
12/17 06:29 am
The Motley Fool
Read moreCRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting
12/09 01:00 pm
GlobeNewswire Inc.
Read moremRNA Therapeutics Market Size to Hit USD 48.65 Billion by 2032 due to Advances in Cancer Treatment and Expanding mRNA Vaccine Applications | Research by SNS Insider
12/08 09:00 am
GlobeNewswire Inc.
Read more2 Biotech Stocks to Buy Hand Over Fist in December
12/07 09:45 am
The Motley Fool
Read moreMeet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More than 65%
11/30 05:35 am
The Motley Fool
Read moreDown 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip?
11/24 06:47 am
The Motley Fool
Read more3 Monster Stocks in the Making
11/23 07:30 am
The Motley Fool
Read moreIs It Too Late to Buy Viking Therapeutics Stock?
11/17 08:05 am
The Motley Fool
Read moreWhere Will CRISPR Therapeutics Be in 3 Years?
11/15 06:45 am
The Motley Fool
Read more3 Unstoppable Growth Stocks I'm Loading $25,000 Each Into by 2029
11/13 07:30 am
The Motley Fool
Read moreCathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
11/08 02:22 pm
The Motley Fool
Read moreThe Ultimate Biotech Stock to Buy With $50 Right Now
10/26 06:32 am
The Motley Fool
Read more3 Bargain Stocks to Buy in a Market That's Priced for Perfection
10/19 07:30 am
The Motley Fool
Read moreWhy I Keep Buying These 14 Incredible Growth Stocks
10/16 09:45 am
The Motley Fool
Read moreIs CRISPR Therapeutics Stock a Buy?
10/13 06:30 am
The Motley Fool
Read more2 Biotech Stocks That Are Screaming Buys This Month
10/12 08:30 am
The Motley Fool
Read moreThis Healthcare Growth Stock Could Be a Steal of a Deal Right Now
10/05 04:25 am
The Motley Fool
Read moreThese 2 Healthcare Stocks With Big Catalysts on the Horizon Can Make You Richer
10/02 04:55 am
The Motley Fool
Read more3 Dirt Cheap Stocks to Buy Right Now
09/21 07:36 am
The Motley Fool
Read moreDown 21% This Year, Is CRISPR Therapeutics Stock Still a Buy?
09/19 04:33 am
The Motley Fool
Read moreLooking for Stock Bargains With Room to Run? Try This.
09/11 04:07 pm
The Motley Fool
Read moreGlobal Genetic Engineering Market Size To Worth USD 8.95 Billion By 2033 | CAGR Of 20.82%
09/10 05:00 am
GlobeNewswire Inc.
Read moreGene Editing Therapeutics Market Forecast 2024-2029: A $1 Billion Market by 2029, with a Forecasted CAGR of 147%
09/10 04:51 am
GlobeNewswire Inc.
Read moreDown Nearly 50% From Its 52-Week High, Is CRISPR Therapeutics a Steal of a Deal?
09/05 08:45 am
The Motley Fool
Read more3 Monster Biotech Stocks to Buy Before 2025
09/02 06:15 pm
The Motley Fool
Read moreIs DexCom a Millionaire-Maker Stock?
09/02 07:12 am
The Motley Fool
Read morePrediction: These Could Be the Best-Performing Biotech Stocks Through 2030
08/26 07:30 am
The Motley Fool
Read moreGot the Market Sell-Off Blues? Do These 3 Things Right Now
08/11 07:28 am
The Motley Fool
Read moreThe Zacks Analyst Blog Vertex Pharmaceuticals CRISPR and Moderna
08/09 04:30 am
Zacks Investment Research
Read more3 Conviction Bets Cathie Wood Is Doubling Down On
08/07 02:43 am
Investing.com
Read moreCathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
07/31 09:45 am
The Motley Fool
Read moreWhat's in Store for ADMA Biologics (ADMA) in Q2 Earnings? - Zacks Investment Research
07/22 10:01 am
Zacks Investment Research
Read moreCould CRISPR Therapeutics Become the Next Vertex Pharmaceuticals? - The Motley Fool
07/16 04:15 am
The Motley Fool
Read moreVertex (VRTX) Rises 16.5% YTD: Time to Bet On the Stock?
06/27 09:54 am
Zacks Investment Research
Read moreIs CRISPR Therapeutics Stock a Buy? One Analyst Thinks the Biotech Is "Very Undervalued."
06/27 08:00 am
The Motley Fool
Read moreCRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing
06/26 06:00 pm
Zacks Investment Research
Read moreIs Most-Watched Stock CRISPR Therapeutics AG (CRSP) Worth Betting on Now?
06/24 09:00 am
Zacks Investment Research
Read moreCRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note
06/20 06:00 pm
Zacks Investment Research
Read moreEditas (EDIT) Reports Upbeat New Data From Reni-Cel Studies
06/17 08:13 am
Zacks Investment Research
Read moreCRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know
06/13 05:50 pm
Zacks Investment Research
Read moreCRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know
06/11 09:00 am
Zacks Investment Research
Read moreCathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought
06/09 06:20 am
The Motley Fool
Read moreWhy Is CRISPR Therapeutics (CRSP) Up 12% Since Last Earnings Report?
06/07 11:30 am
Zacks Investment Research
Read moreCathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You?
06/04 06:45 am
The Motley Fool
Read moreCrispr Therapeutics' Strategic Moves Amidst Gene Therapy Challenges (Rating Upgrade)
06/03 01:35 am
Seeking Alpha
Read more